These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4813581)

  • 21. A modification of the (75Se) selenomethionine assay for the detection of complement-dependent antibody in human tumor systems.
    Avis IL; Avis FP
    J Surg Oncol; 1983 Apr; 22(4):231-5. PubMed ID: 6834843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic evaluation of human bladder cancer: in vitro studies.
    Elhilali MM; Nayak SK
    Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 25. Immune response of prostatic cancer patients to cytomegalovirus-infected and -transformed human cells.
    Laychock AM; Geder L; Sanford EJ; Rapp F
    Cancer; 1978 Oct; 42(4):1766-71. PubMed ID: 81717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.
    Daly JJ; Prout GR; Ahl CA
    J Urol; 1973 Feb; 109(2):253-60. PubMed ID: 4631147
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Glomeruli with IgM-tumor-antigen complex.
    Jones LW
    N Engl J Med; 1975 Sep; 293(11):559. PubMed ID: 1152884
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
    Elhilali MM; Nayak SK
    Invest Urol; 1975 Jul; 13(1):60-6. PubMed ID: 49333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 33. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cell line from an anaplastic transitional cell carcinoma of human urinary bladder.
    Nayak SK; O'Toole C; Price ZH
    Br J Cancer; 1977 Feb; 35(2):142-51. PubMed ID: 836756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immunity to nephroblastoma.
    Diehl V; Jereb B; Stjernswärd J; O'Toole C; Ahström L
    Int J Cancer; 1971 Mar; 7(2):277-84. PubMed ID: 4325850
    [No Abstract]   [Full Text] [Related]  

  • 36. The detection of transitional cell bladder cancer antigen on established cell lines.
    Boxer RJ; Sofen H; Saxon A
    Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
    [No Abstract]   [Full Text] [Related]  

  • 37. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological status of patients with bladder cancers (transitional cell tumours).
    Frantz P; Khoury S; Kuss R
    Prog Clin Biol Res; 1984; 162A():201-8. PubMed ID: 6385023
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
    Bloom ET
    Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Cytotoxic lymphocytes from normal donors.
    Kay HD; Sinkovics JG
    Lancet; 1974 Aug; 2(7875):296-7. PubMed ID: 4136186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.